{
    "symbol": "YTEN",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-11 03:52:06",
    "content": " Our strategy to build shareholder value is to commercialize Camelina as a platform crop to produce renewable products focused on feedstock oils for biofuels in the near term, and to leverage our advances in crop development to launch a elite Omega-3 Camelina varieties and PHA Camelina varieties for PHA bioplastics in the future. As we progress into the second half of 2022, we will continue to focus on executing our key milestones, including expanding our commercial activities targeting the biofuels market, continue to build our differentiated elite Camelina germplasm collection, collecting and analyzing data from our 2022 field testing program and executing a seed scale-up program, and advancing the optimization of our PHA bioplastic and progressing the commercial launch plan for Camelina Omega-3 oils."
}